Gapping up
In reaction to earnings/guidance:
- CHPT +2.8%, DBI +1.8%, DCI +0.7%
Other news:
- CPTN +9.2% (receives non-binding LoI for a $100 mln investment from Koito Manufacturing)
- SRNE +7.2% (receives FDA Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%)
- MREO +6.7% (sends letter to Rubric Capital Management; Letter reiterates Mereo's updated strategic plan to maximize value for all shareholders and corrects Rubric's assumptions; Announces further extension of cash runway into Q2 2025)
- CACI +4.3% (awarded $5.7 bln US Air Force blanket purchase agreement)
- ZEV +3.2% (enters into purchase agreement for up to $50 mln with Lincoln Park Capital)
- NFLX +1.8% (NFLX names two SNAP execs to lead its ads business according to AdAge)
- DBRG +1.7% (DBRG and EQIX in final round of talks for data center business of Malaysia's Time Dotcom unit according to Bloomberg)
- JELD +1.5% (initiates strategic review for its Australasia business)
- SAP +1.2% (names Dominik Asam as new CFO)
- BCRX +1.2% (FDA grants orphan drug designation for BCX9250 for the treatment of fibrodysplasia ossificans progressiva)
- PRVA +1% (its ACOs achieved shared savings of $99.9 mln through Medicare Shared Savings Program)
Analyst comments:
- PYPL +2.4% (upgraded to Buy from Neutral at BofA Securities)
- ASML +1.2% (upgraded to Buy from Neutral at UBS)